[HTML][HTML] TIPS: 25 years later

M Rössle - Journal of hepatology, 2013 - Elsevier
In the 25 years since the first TIPS intervention has been performed, technical standards,
indications, and contraindications have been set up. The previous considerable problem of …

The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis

S Møller, F Bendtsen - Liver International, 2018 - Wiley Online Library
Patients with cirrhosis and portal hypertension often develop complications from a variety of
organ systems leading to a multiple organ failure. The combination of liver failure and portal …

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

D Tripathi, AJ Stanley, PC Hayes, S Travis… - Gut, 2020 - gut.bmj.com
These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial

RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra… - Gastroenterology, 2014 - Elsevier
Background & Aims Little is known about whether probiotics can affect outcomes of patients
with cirrhosis and hepatic encephalopathy (HE). We assessed the efficacy of a probiotic …

The 20% rule of NASH progression: the natural history of advanced fibrosis and cirrhosis caused by NASH

R Loomba, LA Adams - Hepatology, 2019 - journals.lww.com
A Prospective Study Identifying Predictive Factors of Cardia... : Hepatology A Prospective
Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular …

Cardiovascular complications of cirrhosis

S Møller, JH Henriksen - Postgraduate medical journal, 2009 - academic.oup.com
Cardiovascular complications of cirrhosis include cardiac dysfunction and abnormalities in
the central, splanchnic and peripheral circulation, and haemodynamic changes caused by …

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

S Wiese, JD Hove, F Bendtsen, S Møller - … reviews Gastroenterology & …, 2014 - nature.com
Cirrhosis is known to cause alterations in the systemic haemodynamic system. Cirrhotic
cardiomyopathy designates a cardiac dysfunction that includes impaired cardiac contractility …

[HTML][HTML] Cirrhotic cardiomyopathy

S Møller, JH Henriksen - Journal of hepatology, 2010 - Elsevier
Increased cardiac output was first described in patients with cirrhosis more than fifty years
ago. Later, various observations have indicated the presence of a latent cardiac dysfunction …

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

A Krag, F Bendtsen, JH Henriksen, S Møller - Gut, 2010 - gut.bmj.com
Objectives: Recent studies suggest that cardiac dysfunction precedes development of the
hepatorenal syndrome. In this follow-up study, we aimed to investigate the relation between …

Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications

C Matyas, G Haskó, L Liaudet, E Trojnar… - Nature Reviews …, 2021 - nature.com
The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …